Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 8

1.

Treating Women Who Are Pregnant and Parenting for Opioid Use Disorder and the Concurrent Care of Their Infants and Children: Literature Review to Support National Guidance.

Klaman SL, Isaacs K, Leopold A, Perpich J, Hayashi S, Vender J, Campopiano M, Jones HE.

J Addict Med. 2017 Apr 13. doi: 10.1097/ADM.0000000000000308. [Epub ahead of print]

PMID:
28406856
2.

A statewide screening, brief intervention, and referral to treatment (SBIRT) curriculum for medical residents: Differential implementation strategies in heterogeneous medical residency programs.

Pringle JL, Kearney SM, Rickard-Aasen S, Campopiano MM, Gordon AJ.

Subst Abus. 2017 Feb 8:1-7. doi: 10.1080/08897077.2017.1288195. [Epub ahead of print]

PMID:
28332942
3.

Amyloid-β 11C-PiB-PET imaging results from 2 randomized bapineuzumab phase 3 AD trials.

Liu E, Schmidt ME, Margolin R, Sperling R, Koeppe R, Mason NS, Klunk WE, Mathis CA, Salloway S, Fox NC, Hill DL, Les AS, Collins P, Gregg KM, Di J, Lu Y, Tudor IC, Wyman BT, Booth K, Broome S, Yuen E, Grundman M, Brashear HR; Bapineuzumab 301 and 302 Clinical Trial Investigators..

Neurology. 2015 Aug 25;85(8):692-700. doi: 10.1212/WNL.0000000000001877. Epub 2015 Jul 24.

4.

National and State Treatment Need and Capacity for Opioid Agonist Medication-Assisted Treatment.

Jones CM, Campopiano M, Baldwin G, McCance-Katz E.

Am J Public Health. 2015 Aug;105(8):e55-63. doi: 10.2105/AJPH.2015.302664. Epub 2015 Jun 11.

5.

Use of pharmacotherapies in the treatment of alcohol use disorders and opioid dependence in primary care.

Lee J, Kresina TF, Campopiano M, Lubran R, Clark HW.

Biomed Res Int. 2015;2015:137020. doi: 10.1155/2015/137020. Epub 2015 Jan 5. Review.

6.

Two phase 3 trials of bapineuzumab in mild-to-moderate Alzheimer's disease.

Salloway S, Sperling R, Fox NC, Blennow K, Klunk W, Raskind M, Sabbagh M, Honig LS, Porsteinsson AP, Ferris S, Reichert M, Ketter N, Nejadnik B, Guenzler V, Miloslavsky M, Wang D, Lu Y, Lull J, Tudor IC, Liu E, Grundman M, Yuen E, Black R, Brashear HR; Bapineuzumab 301 and 302 Clinical Trial Investigators..

N Engl J Med. 2014 Jan 23;370(4):322-33. doi: 10.1056/NEJMoa1304839.

7.

Pennsylvania SBIRT Medical and Residency Training: developing, implementing, and evaluating an evidenced-based program.

Pringle JL, Melczak M, Johnjulio W, Campopiano M, Gordon AJ, Costlow M.

Subst Abus. 2012;33(3):292-7. doi: 10.1080/08897077.2011.640091.

PMID:
22738008
8.

Effect of tarenflurbil on cognitive decline and activities of daily living in patients with mild Alzheimer disease: a randomized controlled trial.

Green RC, Schneider LS, Amato DA, Beelen AP, Wilcock G, Swabb EA, Zavitz KH; Tarenflurbil Phase 3 Study Group..

JAMA. 2009 Dec 16;302(23):2557-64. doi: 10.1001/jama.2009.1866.

Supplemental Content

Loading ...
Support Center